Associated Papers
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study.
Giovanella S et al.
Clinical Genetics, 2026
40533884 (PubMed )
Supplement: CGE-109-136-s001.docx
Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease.
Janssens P et al.
Kidney International Reports, 2021
34169210 (PubMed )
Supplement: mmc1.pdf
Fundamental insights into autosomal dominant polycystic kidney disease from human-based cell models.
Weydert C et al.
Pediatric Nephrology (berlin, Germany), 2019
Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease.
Berckmoes V et al.
Human Reproduction (oxford, England), 2019
Novel Mutations in the PKD1 and PKD2 Genes of Chinese Patients with Autosomal Dominant Polycystic Kidney Disease.
Xu D et al.
Kidney & Blood Pressure Research, 2018
Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases.
Liu Y et al.
Plos One, 2015
Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.
Mekahli D et al.
Pflugers Archiv : European Journal of Physiology, 2014
Select a paper to view details